What is BSEM's gross margin?

BioStem (BSEM) has a gross margin of 53% and a net margin of -114%.

What is BSEM's P/E ratio?

Track BioStem (BSEM) P/E ratio, ROE, and valuation metrics over time.

Where can I see BSEM's full financials?

See BioStem (BSEM) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

BioStem (BSEM) Financials — Revenue, Earnings, Cash Flow

$2.73

-0.34 (-11.07%)

Weekly Expected Move ±16.0%

$2 $2 $3 $3 $4

NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 30 · $46.4M mcap · 13M float · 0.772% daily turnover · Short 35% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest Supply Chain

📊 Key Metrics

TTM

$-60M

Revenue

-119.6% YoY

$-28M

Net Income

-207.7% YoY

$-9M

Free Cash Flow

-133.5% YoY

52.6%

Gross Margin

-106.3%

Op. Margin

-113.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-74.7%

ROA-35.1%

ROIC-84.3%

Valuation

P/E-1.6

P/B1.7

EV/EBITDA-2.3

Leverage

Debt/Equity0.04

Current Ratio0.98

Interest Cov.0.0x

Quality Scores

Piotroski F2/9

Altman Z-2.32

Beneish M-1.94